header website Rosalie Luiten


About me


My research



Science & Society


Prof. Rosalie M. Luiten PhD

Logo SNIPDepartment of Dermatology and
The Netherlands Institute for Pigment Disorders
Academic Medical Center
University of Amsterdam
Meibergdreef 9, room L3-116
NL-1105 AZ Amsterdam
The Netherlands


Research experience:

2014 - present: Full professor in Experimental Dermatology with focus on pigment cell disorders of the skin at the University of Amsterdam.
2012 to present: Associate professor at the department of Dermatology, Academic Medical Center
2008 to present: Head of the Laboratory of Experimental Dermatology
2007 to present: AMC principal investigator (PI)
2005-present: Assistant professor at the Netherlands Institute for Pigment Disorders and department of Dermatology of the Academic Medical Center of the University of Amsterdam. Studying the pathogenesis of vitiligo and its application in immunotherapy of melanoma. Supervisor of two PhD students, one Postdoctoral fellow, two technicians and one MSc student.

Awarded in 2005 a research grant of €460,000 from the Dutch Cancer Society to study the susceptibility of melanoma for autoimmune attack, an important prognostic factor for the potential success of immunotherapy in combating melanoma.

Senior Postdoctoral Research Fellow at the Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden. Awarded a research grant (€ 110,000) from the Netherlands Institute of Pigment Disorders at the University of Amsterdam to start a new research line on the pathogenesis of vitiligo and its application in immunotherapy of melanoma.

In 2004, awarded the NWO-VIDI personal grant of € 600.000 from the Innovational Research Program of the Dutch Organization of Scientific Research (NWO).

Postdoctoral Research Fellow at the Department of Immunology, The Netherlands Cancer Institute / Antoni van Leeuwenhoek hospital, Amsterdam. Developed innovative immunotherapeutic strategies, including autologous tumor cell vaccines and immortalized human T lymphocytes, for the treatment of melanoma. Treatment evaluation performed both in experimental models and in melanoma patients in a Phase I clinical study.

Marie Curie Research Fellow at the Ludwig Institute for Cancer Research (LICR) in Brussels (dr. P. van der Bruggen, Prof. dr. T. Boon).
Marie Curie postdoctoral research fellow at the Christian de Duve Institute of Cellular Pathology, Cellular Genetics Unit, in Brussels. Awarded a personal fellowship (€ 150,000) to work two years in the group of dr. P. van der Bruggen and prof. dr. T. Boon. Developed cancer vaccines derived from MAGE genes. Invented five new cancer vaccines that are patented worldwide for clinical application.


PhD. at the University of Leiden.
Title of the thesis: "New chimeric monoclonal antibodies against human carcinoma. IgE and bispecific antibody-mediated therapy", (Prof. dr. S.O. Warnaar and Prof. dr. G.J. Fleuren); Prof. dr. L.J. Old, Ludwig Institute for Cancer Research, New York, USA (referee).

Doctorandus (MSc.) in Biomedical Sciences, University of Leiden.
French Language and Literature, University of Grenoble III, France, first and second degree.

Share |

. Ontwerp en realisatie: Nico van Dijk Media


Valid HTML 4.01 Transitional Valide CSS!